CONTINUING CONNECTED TRANSACTIONS; PROPOSED ADOPTION OF THE 2025 SHARE INCENTIVE SCHEME

 

	Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (06990)

► (a) 2026 Promotional Services Framework Agreement ► (b) 2026 Auxiliary R&D Services Framework Agreement ► (c) 2026 Procurement and Sale of Equipment and Materials Framework Agreement ► (d) Written Consent from Altus Capital Limited ► (e) 2025 Share Incentive Scheme